Newlect 1 mg (Rasagiline Mesilate)

Adult dose

This medicine is administered orally to adults once daily as monotherapy or adjunctive therapy. 1) Monotherapy or adjunctive therapy with a dopamine agonist: Administer 1mg orally once daily. 2) Adjunctive therapy with levodopa: The recommended initial dose for patients taking levodopa is 0.5mg once daily. If well tolerated and the clinical response is insufficient, the dose may be increased to 1mg once daily. This medicine may be taken with or without food.

This medication should not be used in patients who have allergies to the active ingredient or any other components of this medicine. It should not be administered to patients who are taking or have discontinued other MAO inhibitors within the past two weeks. Furthermore, it should not be used in patients who are taking or have stopped taking certain medications such as petidine, tramadol, or dextromethorphan within the past two weeks. Patients with moderate to severe liver dysfunction should not take this medicine. When taking this medicine, various side effects such as headache, dizziness, skin rash, nausea, insomnia, arthralgia, hallucinations, and depression may occur, and caution is required. Especially in Parkinson's patients, psychiatric symptoms such as hallucinations or confusion may arise. This medication can elevate blood pressure, so it is important to avoid excessive intake of foods high in tyramine. When used in conjunction with other dopaminergic therapies, drowsiness or sudden sleep may occur; therefore, caution is required when driving or operating machinery. Patients with compromised liver or kidney function require careful dosage adjustment or monitoring, and in severe cases, administration should be avoided. This medicine can affect the ability to drive or operate dangerous machinery, so caution is needed while taking it. Pregnant or breastfeeding women should use this medicine with caution, and consultation with a healthcare professional is required due to the possibility of interfering with breastfeeding. Safety in children has not been established, and no special dosage adjustment is typically needed for elderly patients. In case of overdose, there is no specific antidote, and immediate medical supervision and appropriate treatment are necessary. This medication should be stored out of reach of children, at temperatures between 1 and 25 degrees Celsius, and transferring to other containers should be avoided.

Influenza

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, in a cool place with a temperature between 1 and 25 degrees Celsius. It is crucial to avoid direct sunlight and to keep it away from extremely hot or cold places.

Appearance

White round tablet

Package unit

30 tablets/bottle